BioPharma
02 August, 2026 | Sunday | Expert Insight
Advancing Freeze-to-Store Workflows for the Next Era of Biopharmaceutical Manufacturing
As biologics, biosimilars, and advanced cell and gene therapies continue to reshape the Asia-Pacific biopharmaceutical landscape, manufacturers are under increasing pressure to enhance cold ch...
Lab
30 July, 2026 | Thursday | News
Eppendorf to Invest EUR 40 Million in New Penang Manufacturing Facility
Eppendorf has signed an agreement for a new production site in Penang, Malaysia, marking the start of its planned greenfield manufacturing facility in Bandar Cassia Technology Park. The company is investing EUR...
BioTech
30 July, 2026 | Thursday | News
Eppendorf to Invest EUR 40 Million in New Penang Manufacturing Facility
Eppendorf has signed an agreement for a new production site in Penang, Malaysia, marking the start of its planned greenfield manufacturing facility in Bandar Cassia Technology Park. The company is investing EUR...
Contract Services
24 July, 2026 | Friday | News
Samsung Bioepis Secures Exclusive Commercial Rights to Nectin-4 ADC Candidate SBE303
Ÿ Under the agreement, Samsung Bioepis will obtain exclusive commercial licensing rights to SBE303, an ADC candidate currently in joint development Ÿ This agreement ...
Consumer Health
28 July, 2026 | Tuesday | News
Roche Secures US FDA Clearance for PCR Test Detecting Bacterial Vaginosis and Candida Vaginitis
The new PCR test uses clinician-collected or clinician-instructed, self-collected vaginal swab specimens to simultaneously detect organisms associated with Bacterial vaginosis (BV) and Candida ...
Medtech
28 July, 2026 | Tuesday | News
Advita Introduces Activit-E Vitamin E Polyethylene to Equinoxe Reverse Shoulder System
Advita Ortho, a global medical technology leader, announced the first clinical use of humeral liners manufactured with Activit-E® polyethylene, bringing its advanced vitamin E polyethylene technology ...
Cell & Gene
03 August, 2026 | Monday | News
CellOrigin Advances In Vivo Cell Therapy Pipeline with ASCO Data and Walvax Partnership
CellOrigin, a biotechnology company focused on next-generation in vivo and in vitro cell therapy technologies, has announced two major progresses in both research and strategic partnership. At the 2026 AS...
White Paper
02 August, 2026 | Sunday | Analysis
7 Manufacturing Technologies Moving From Pilot to Plant in APAC
Product Spot Light
30 July, 2026 | Thursday | News
Eppendorf to Invest EUR 40 Million in New Penang Manufacturing Facility
Premium Article
29 July, 2026 | Wednesday | Analysis
8 APAC Assets That Went Global The Out-Licensing Class of 2025 to 2026
Bio Invest
03 August, 2026 | Monday | News
IMPACT Therapeutics Partners with Pharmanovia to Commercialise Senaparib Across Europe, MENA, Australia and New Zealand
Biopharma APAC Infomercial
Most Read
- Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?
- The Algorithm on the GMP Floor: AI Promises a Smarter Plant. Regulators Demand the Audit Trail.
- APAC's Peptide-Capacity Gamble
- After the Rush: APAC's mRNA and Vaccine Capacity Hangover
- The Biosimilar Race: Factory to the World — or Stuck in the Copycat Economy?
- The Vein-to-Vein Problem: Can APAC's Cold Chain Carry Advanced Therapies?
- Vectors, Plasmids and the CGT Trap: APAC's Cell and Gene Therapy Ambitions Face an Upstream Bottleneck
- Can APAC Build Radioligand Therapy Before the Atoms Decay?
- The Great Biopharma Reset: 50 Developments That Changed Everything in H1 2026
- Beyond the Trial: Can Real-World Evidence Earn Regulatory Trust in APAC?
- Beyond the Obvious Giant: Where APAC's Clinical Trials Go Next
- The Frontier That Won’t Quite Arrive
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
